Background Despite recent studies, the optimum duration of dual antiplatelet therapy
(DAPT) after coronary drug-eluting stent placement remains uncertain. We performed a meta …

Bioprostheses are prone to structural valve degeneration, resulting in limited long-term
durability. A significant challenge when comparing the durability of different types of …

Current generation of drug-eluting stents has significantly improved the outcomes of
percutaneous coronary intervention by substantially reducing in-stent restenosis and stent …

Background We have previously reported a virtual absence of neointimal hyperplasia 4
months after implantation of sirolimus-eluting stents. The aim of the present investigation …

Background—Restenosis remains an important limitation of interventional cardiology.
Therefore, we aimed to determine the safety and efficacy of sirolimus (a cell-cycle inhibitor) …

Background Patients at high risk for bleeding who undergo percutaneous coronary
intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet …

Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …

Objectives. We compared the clinical outcomes following coronary stent implantation in
insulin-treated diabetes mellitus (IDDM), non-IDDM patients, and nondiabetic patients …

Background Our aims were to compare coronary artery bypass grafting (CABG) and stenting
for the treatment of diabetic patients with multivessel coronary disease enrolled in the …

Background—The goal of this intravascular ultrasound investigation was to provide a more
detailed morphological analysis of the local biological effects of the implantation of a …